By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biodesix, Inc. 

2970 Wilderness Place
Suite 100
Boulder  Colorado  80301  U.S.A.
Phone: 303-417-0500 Fax: n/a



Company News
New Data Show Biodesix, Inc.’s VeriStrat Test Is Cost-Saving, Improves Survival And Quality Of Life In Advanced Lung-Cancer Patients 4/4/2017 2:49:47 PM
Blood-Based Diagnostic Assay From Biodesix, Inc. Measures Immunotherapy Biomarker PD-L1 2/27/2017 11:33:13 AM
Biodesix, Inc. Release: GeneStrat Liquid Biopsy Testing Now Includes ROS1 And RET Mutations 2/2/2017 10:27:27 AM
Biodesix, Inc. Release: Clin-TOF Successfully Integrated Into VeriStrat Workflow 1/27/2017 7:02:49 AM
Beijing's Bioyong Forms $38 Million IVD Collaboration With Biodesix, Inc. 1/12/2017 11:11:12 AM
Biodesix, Inc. And Bioyong Announce Agreement For Joint Development And Commercialization Of Veristrat Test In Greater China 1/9/2017 11:10:10 AM
Biodesix, Inc.' VeriStrat Test Now Covered By Humana, Medical Mutual Of Ohio, PreferredOne 11/1/2016 11:42:35 AM
Biodesix, Inc. Release: Veristrat Test Identifies Patients With Squamous Cell Carcinoma Of The Lung Who Are More Likely To Have Improved Survival On Afatinib Therapy 10/5/2016 8:48:58 AM
Norgen Biotek Corporation Announces Supply Agreement With Biodesix, Inc. The First EML4-ALK Liquid Biopsy Test With Results In 72-Hours 3/2/2016 6:57:02 AM
Biodesix, Inc. Release: Investigational Blood Test Identifies Patients With Melanoma Who Are More Likely To Have Improved Survival On Nivolumab Therapy 11/3/2015 7:41:49 AM